Author Archive
- Which Eye Doctors Use Lasers to Treat Floaters?
- Regenerating the Retina
- A New Approach for Repairing/Rejuvenating Damaged Photoreceptors
- Gene Therapy in Ophthalmology Tables Updated
- Stem Cells/Cell Therapy in Ophthalmology Tables Updated
- DARPins Phase 2 Trial Results Fall Short
- Results of The AREDS2 HOME Study of Notal Vision’s Home Monitoring Device for AMD Announced
- Oxford BioMedica Gene Therapy Clinical Trials Resume
- New Gene Therapy Company, Spark Therapeutics, Launches
- Patient Advisory for Stem Cell Therapy and Medical Tourism
- A New Virus Vector for Safer Delivery of Gene Therapies in Ophthalmology
- New Technology Pioneered by Dr. Sheila Nirenberg May Restore Vision By Bypassing Damaged Photoreceptors
- Patient in ACTC Stem Cell Clinical Trial With Dry AMD Goes from Legally Blind (20/400) to Near Normal Vision (20/40)
- Current Status of Stem Cells and Gene Therapy in Ophthalmology
- RetroSense Using Optogenetics to Treat Retinitis Pigmentosa and Dry AMD
- Hemera Biosciences Obtains Initial Funding for Gene-based Treatment for AMD
- DARPins, The Next “Game Changer” for Wet AMD?
- Visual Aids for Visually Challenged Patient with Stargardt’s Disease
- New Vitamin Regimen Could Extend Useful Vision for Up to 20 Years for Sufferers of Retinitis Pigmentosa and Certain Types of Usher Syndrome
- Update from Maurie Hill – Patient Participating in Clinical Trial to Treat Stargardt’s With Stem Cells
- Good News for Patients With Stargardt’s Disease
- Early Positive Results in Ongoing Gene Therapy Trials for Wet AMD and Stargardt’s
- Patient Enrolled in Advanced Cell Technology’s Stem Cell Clinical Trial Shares Her Story
- 2nd Clinical Site for Gene Therapy Trial for Usher Syndrome
- First Gene Therapy Approval on the Horizon: The Impact on Ophthalmology
- How Fovista Works to Increase Vision in the Treatment of Wet AMD: The Science Behind the Combined Therapy
- Everything You Wanted to Know About Stem Cells in Ophthalmology
- Two-Year CATT Study of Results for Avastin vs. Lucentis in Treating Wet AMD
- Retinitis Pigmentosa Treatment Update
- ACT Adds Third Clinical Trial Site for Testing Treatment of Dry Macular Degeneration With Embryonic Stem Cells
- Stem Cells Inc. Gets FDA Authorization to Initiate Clinical Trial to Use Human Neural Stem Cells to Treat Dry AMD
- Gene Therapy Curing X-Linked Retinitis Pigmentosa in Dogs Paves the Way for Similar Treatment in Humans
- Can Gene Therapy Help Treat Usher Syndrome Patients with Retinitis Pigmentosa?
- Will Macular Degeneration Eventually Be Treated With Eye Drops?
- Potential Major Breakthrough in Treatment of Wet Age-Related Macular Degeneration
- Visualization of Drusen and RPE With New Software Application for Zeiss HD-OCT: A New Aid for Assessing Both Dry and Wet AMD
- First Clinical Results of Using Embryonic Stem Cells to Treat Eye Disease Published in The Lancet
- Will 2012 be the Year for Gene Therapy in Ophthalmology?
- A Complete List of Current Ophthalmic Stem Cell Trials
- Progress Made in Treating Stargardt’s and Dry AMD Using Embryonic Stem Cells
- New Gene Therapy Approach to Treating GA and Dry AMD
- Fighting Retinal Disease: The Promise of New Approaches
- Six New Gene Therapy Projects Funded by Foundation Fighting Blindness
- Catheter Used to Deliver Stem Cells to Macula to Treat Geographic Atrophy in Dry AMD
- Gene Therapy Trial for Retinitis Pigmentosa Based on Usher’s Syndrome To Begin
- ACT Expands Embryonic Stem Cell Treatment for Stargardt’s to UK
- Contaminated Repackaged Avastin Causes Severe Eye Infections and Blindness
- First Patients With Macular Degeneration and Stargardt’s Disease Receive Stem Cell Treatment
- Visualization of Living Rods and Cones in Retina
- Using Stem Cells to Treat Dry AMD and Stargardt’s Macular Dystrophy
- A Potential Breakthrough in the Treatment of Glaucoma: Implant May Change Paradigm of Treatment
- Research Studies with Induced Pluripotent Stem Cells Suggest Opposite Results
- Quick Updates from ARVO 2011
- Avastin vs. Lucentis: The Origin of the Debate
- CATT Study Finds No Difference Between Avastin and Lucentis in Stopping Progression of Wet Macular Degeneration
- Drug Eluting Device Slows Vision Loss in Geographic Atrophy Brought on by Dry AMD
- What Are the Commercially Available Femtosecond Lasers for Refractive and Other Eye Surgeries?
- Advanced Cell Technology Obtains FDA Approval to Treat Dry AMD with Embryonic Stem Cells
- FDA Delays Approval of Iluvien to Treat Diabetic Macular Edema
- Advanced Cell Technology Files Application for Trial to Treat Dry AMD With Human Embryonic Stem Cells
- Stargardt Disease To Be Treated With Embryonic Stem Cells in Trial Initiated by Advanced Cell Technology
- The Use of Gene Therapy in Treating Retinitis Pigmentosa and Dry AMD
- Will the AdaptDx Device Assist With Early Detection of AMD?
- AstraZeneca to Develop Stem Cell Treatments
- What is the Future of Stem Cells in Treating Eye Disease?
- How Soon Will Iluvien be Available to Treat Diabetic Macular Edema?
- Will Femtosecond Laser Technique Postpone the Need for Cataract Surgery?
- Should Lasers Be Used to Treat Eye Floaters?
- Is Iluvien From Alimera Sciences the Future of Ophthalmic Drug Delivery?
- Updated Clinical Results for Ellex 2RT Laser Therapy
- The Story Behind the Invention of Avastin and Lucentis
- Potential Breakthrough in Creating Artificial Retina from Human Embryonic Stem Cells
- On Demand Therapeutics Announces Novel Drug Delivery System for AMD
- An Overview of Current Anti-VEGF Protocols for AMD
- The Notal Vision ForeseeHome Monitor for AMD
- The London Project To Cure Blindness – An Update
- An Overview of New Treatments for Dry AMD
- Color-Changing Contact Lenses To Replace Blood Tests for Diabetics
- The First Ophthalmic Innovation Summit
- Oraya IRay In-office Stereotactic X-ray Treatment for AMD: A First Report
- CMS Reverses the Reimbursement for AVASTIN
- More AAO Highlights: Steroid implants for DME, Gene Therapy for Retinal Dystrophy, and More
- AAO Highlights: Lasers for Cataract Surgery, Laser Vision Correction Trends, and More
- NeoVista®, Inc. Completes Enrollment in Pivotal CABERNET™ Study
- CMS Reverses Position on Avastin for AMD
- Interesting News from the 2009 AAO Meeting from Ellex, NeoVista, Presbia and Others
- Which is More Effective – Avastin or Lucentis?
- Update on Avastin vs. Lucentis: CMS Ups the Ante
- Roche and Genentech Strike Deal With Surmodics For Biodegradable Microparticle Drug Delivery System for Lucentis
- Endo Optiks Introduces New High Resolution Endoscopes
- Can the Blood Vessels in Your Retina Predict Your Risk of Heart Disease?
- Avastin versus Lucentis Comparative Studies Proliferate – France Joins the Fray
- LenSx Obtains First Femtosecond Laser Approval for Capsulotomies
- The History of Customized Corneal Ablation (Custom LASIK)
- Technolas Eyetracking Technology Approved For LASIK Surgery by FDA
- New Laser Treatment to Halt Blindness
- Lucentis Improves Vision in Retinal Vein Occlusions
- Team of Researchers Discovers Biological Marker for Age-Related Macular Degeneration
- Can Femtosecond Lasers Be Used for Cataract Surgery?
- Future Applications of the Femtosecond Laser
- Palomar Medical Technologies Secures OTC Clearance from FDA for Home Use Laser To Treat Eye Wrinkles
- Can Femtosecond Laser Be Used to Correct Myopia?
- Implantable Contact Lenses for Myopia
- Summary of Surgical Techniques to Correct Presbyopia
- The Pursuit of Implants to Correct Presbyopia
- New Indications for the Femtosecond Laser in Eye Surgery
- Bausch & Lomb Akreos® AO IOL Granted New Technology Intraocular Lens (NTIOL) Designation
- Avedro Using Microwave Technology to Change Shape of Cornea to Correct Vision
- ARVO 2009 Meta Analysis of Diabetic Retinopathy
- Potential Nanotechnology Answer to Malfunctioning Retina
- A Preview of this Year’s Annual Meeting of the Association for Research in Vision and Technology (ARVO)
- On Demand Lucentis as Effective as Monthly Injections – Two-Year PRONTO Study
- Two Years of Avastin: Re-Treatment Study
- B&L and 20/10 Perfect Vision form Technolas Perfect Vision
- Bayer and Regeneron Expand VEGF Trap-Eye to CRVO
- OptiMedica Corp. Presentations at ARVO 2009 to Cover PASCAL Laser Technology
- TransMolecular, Inc. Presentation at ARVO 2009
- Sirion Therapeutics Presentation at ARVO 2009
- Optherion Pharmaceutical Presentations at ARVO 2009
- ARVO 2009 Presentations – StemCells, Inc.
- Acucela Presentations at ARVO 2009
- Inotek Pharmaceuticals Presentations at ARVO 2009
- pSivida Corp Presentations at ARVO 2009
- Resolvyx Pharmaceuticals Presentations at ARVO 2009
- Embryonic Stem Cell Treatment for AMD
- Sirion Therapeutics Announces Positive Results from Phase II Trials Evaluating Fenretinide for Treatment of Geographic Atrophy and Receipt of Fast Track Designation from the FDA
- Inlays, Onlays, Rings & Things
- More on the NeoVista Epi-Retinal Strontium 90 Treatment for Wet AMD
- The ELLEX 2RT Retinal Regeneration Laser